DBMR Blogs

  Introduction The  Medical Cannabis Market  refers to the global industry focused on the cultivation, processing, distribution, and use of cannabis and cannabis-derived products for medical purposes. These products are prescribed or recommended to manage chronic pain, neurological disorders, cancer-related symptoms, mental health conditions, and other complex diseases. Unlike recreational cannabis, medical cannabis is regulated and used under medical supervision in most regions. In recent years, the Medical Cannabis Market has gained strong momentum due to changing public perceptions, growing clinical evidence, and evolving regulatory frameworks. Governments across several countries are recognizing the therapeutic potential of cannabis-based medicines. As a result, the market has shifted from a niche segment to a structured healthcare industry with increasing investments and research activity. The Medical Cannabis Market now plays an important role in the global healthca...

  Executive Summary  Medical Cannabis Market  : CAGR Value The global medical cannabis market was valued at USD 25.86 billion in 2024 and is expected to reach USD 133.73 billion by 2032. During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 22.80%, primarily driven by increasing acceptance of cannabis for therapeutic purposes Transparent, trustworthy and extensive market information and data included in this report will definitely help develop business and improve return on investment (ROI). This Medical Cannabis Market report provides an exhaustive survey of key players in the market which is based on a range of objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of an organization. One of the sections in the report covers evaluation of probabilities of the new investment projects and overall research conclusions are offered. Medical Cann...

Introduction The  medical cannabis market  has emerged as a dynamic and rapidly expanding sector in the global healthcare industry. Once shrouded in controversy and legal restrictions, medical cannabis is now gaining widespread acceptance as a legitimate therapeutic option for a range of chronic and acute conditions. As scientific research validates its efficacy and more countries adopt progressive cannabis policies, the market is experiencing significant growth in demand, investment, and innovation. Medical cannabis refers to the use of cannabis and its cannabinoids—primarily THC (tetrahydrocannabinol) and CBD (cannabidiol)—for the treatment or management of medical conditions. These can include chronic pain, epilepsy, multiple sclerosis, cancer-related symptoms, anxiety, and more. Unlike recreational cannabis, medical cannabis is typically regulated, prescribed by healthcare professionals, and consumed in controlled dosages through various delivery forms such as oils, tinctu...

  The   global medical cannabis market   is experiencing significant growth, driven by increasing acceptance of cannabis for therapeutic purposes, the rising prevalence of chronic conditions, and the growing number of countries legalizing medical cannabis. As of 2023, the market size is valued at approximately USD 17.60 billion, with projections indicating it could reach USD 121.33 billion by 2033. This represents a compound annual growth rate (CAGR) of 21.30% from 2023 to 2033. Key Drivers of Market Growth Legalization Trends: The ongoing legalization of medical cannabis in various countries and regions is a major driver for the market. As more governments recognize the therapeutic benefits of cannabis, the market is expanding rapidly. Rising Prevalence of Chronic Diseases: Increasing cases of chronic diseases such as cancer, arthritis, and neurological disorders are leading to higher demand for medical cannabis products for pain management and symptom relief. Growing Pa...